Elevated tumor necrosis factor-α in skeletal muscle after stroke

Stroke

Volumn 36, Issue 9, 2005, Pages 2021-2023

  Hafer Macko, Charlene E ^a,c   Yu, Shuzhen ^a,c   Ryan, Alice S ^b,c   Ivey, Frederick M ^b,c   Macko, Richard F ^a,b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c Geriatrics Research Education Clinical Center   (United States)

Author keywords

Inflammation; Insulin; Stroke; Tumor necrosis factor

Indexed keywords

ACIDIC RIBOSOMAL PHOSPHOPROTEIN; COMPLEMENTARY DNA; MESSENGER RNA; PHOSPHOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; FEMALE; HEMIPARESIS; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC DISORDER; MUSCLE ATROPHY; MUSCLE BIOPSY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; STROKE; VASTUS LATERALIS MUSCLE;

AGED; ATROPHY; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LEG; MALE; MIDDLE AGED; MUSCLE, SKELETAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMES; RNA; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24644441681     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000177878.33559.fe     Document Type: Article

References (13)

1. Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J. 2004;148:S19-S26.
2. Libby P. Inflammation and atherosclerosis. Nature. 2002;420:868-874.
3. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109:II2-I10.
4. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D'Agostino RB, Franzblau C, Wilson PW. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study. Stroke. 2001;32:2575-2579.
5. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNF-alpha by human muscle. Relationship to insulin resistance. J Clin Invest. 1996;97:1111-1116.
6. del Aguila LF, Claffey KP, Kirwan JP. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol. 1999;276:E849-E855.
7. Greiwe JS, Cheng B, Rubin DC Yarasheski KE, Semenkovich CF. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J. 2001;15:475-482.
8. De Deyne PG, Hafer-Macko CE, Ivey FM, Ryan AS, Macko RF. Muscle molecular phenotype after stroke is associated with gait deficit severity. Muscle Nerve. 2004;30:209-215.
9. Kernan WN, Inzucchi SE. Type 2 diabetes mellitus and insulin resistance: stroke prevention and management. Curr Treat Options Neural. 2004;6:443-450.
10. Ryan AS, Dobrovolny CL, Smith GV, Silver KH, Macko RF. Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients. Arch Phys Med Rehabil. 2002;83:1703-1707.
11. Ryan AS, Dobrovolny CL, Smith GV, Silver KH, Mako RF. Cardiovascular fitness after stroke: role of muscle mass and gait deficit severity. J Stroke Cerebro Disease. 2000;9:185-191.
12. Aagaard P, Andersen JL. Correlation between contractile strength and myosin heavy chain isoform composition in human skeletal muscle. Med Sci Sports Exerc. 1998;30:1217-1222.
13. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003;34:2518-2532.